# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-21-003310
Filing Date
2021-05-07
Accepted
2021-05-07 16:18:32
Documents
55
Period of Report
2021-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | bcrx20210331_10q.htm iXBRL | 10-Q | 1186079
2 | EXHIBIT 10.1 | ex_247203.htm | EX-10.1 | 128606
3 | EXHIBIT 10.2 | ex_247204.htm | EX-10.2 | 40930
4 | EXHIBIT 31.1 | ex_245740.htm | EX-31.1 | 12902
5 | EXHIBIT 31.2 | ex_245741.htm | EX-31.2 | 12900
6 | EXHIBIT 32.1 | ex_245742.htm | EX-32.1 | 5883
7 | EXHIBIT 32.2 | ex_245743.htm | EX-32.2 | 5857
| Complete submission text file | 0001171843-21-003310.txt |  | 6301100

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA | bcrx-20210331.xsd | EX-101.SCH | 61169
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | bcrx-20210331_cal.xml | EX-101.CAL | 35122
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | bcrx-20210331_def.xml | EX-101.DEF | 433325
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | bcrx-20210331_lab.xml | EX-101.LAB | 397360
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | bcrx-20210331_pre.xml | EX-101.PRE | 445512
13 | EXTRACTED XBRL INSTANCE DOCUMENT | bcrx20210331_10q_htm.xml | XML | 914496

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 21902949
SIC: 2836 Biological Products, (No Diagnostic Substances)